Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.
AUTOR(ES)
Connolly, K J
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=190549Documentos Relacionados
- Antiretroviral therapy: reverse transcriptase inhibition.
- Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis.
- Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
- Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy